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Saddle pulmonary embolisms are life threatening and are uncommon after IVC ﬁlter placement.
Management of PE is difﬁcult, and emergent thrombolysis is sometimes the only option left if the patient
is hemodynamically unstable. We present a rare case of an acute saddle pulmonary embolism in a patient
with an intact infrarenal IVC ﬁlter presenting with hemodynamic instability.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Saddle pulmonary embolism (PE) is a form of large pulmonary
thrombo-embolism that straddles the main pulmonary arterial
trunk at its bifurcation. Its incidence among patients diagnosed
with PE was found to be approximately 2.6%.1
Saddle PE frequently results in signiﬁcant hemodynamic insta-
bility and signals the potential for imminent hemodynamic
collapse. Unfortunately, the most common presenting symptoms
of dyspnea followed by syncope are relatively non-speciﬁc.1
Consequently, a high index of suspicion and emergent diagnosis
and treatment are of critical importance. The current guidelines for
treatment of large pulmonary embolism by the American College
of Chest Physicians are systemic thrombolytic therapy.2 However,
patients with contraindications to thrombolysis or hemodynami-
cally unstable patients who do not respond to thrombolysis may
require more aggressive treatments. Although there are no ofﬁcial
guidelines recommending catheter directed therapy (CDT) in the
treatment of large pulmonary embolism, its integration has been
recommended and is currently used in many institutions for the
indications listed above.3
In this report, we present a case of a patient who developed
a large saddle PE despite inferior vena cava (IVC) ﬁlter placement 10
days prior. Successful treatment was accomplished through use of
catheter directed thrombolysis and thrombectomy.: þ1 817 920 6229.
rved.2. Case report
The patient is a 45-year-old white male with a history of hy-
pothyroidism, hypertension, obesity, and long history of tobacco
and alcohol abuse. He presented to the emergency room com-
plaining of progressive shortness of breath and cough of two weeks
duration. On physical exam, the patient was found to have bilateral
lower extremity edema, in which duplex sonography revealed
deep venous thrombosis (DVT) of the left superﬁcial femoral vein.
Upon further work up, the patient’s dyspnea was suspected to be
multi-factorial, with components of chronic obstructive pulmonary
disorder (COPD), congestive heart failure (CHF) exacerbation, and
pneumonia. These conditions were treated appropriately, and
anticoagulation therapy for his DVT was initiated. After one week,
the patient was deemed clinically stable for discharge, with an INR
in therapeutic range. He was advised to follow-up with his primary
care physician and the Coumadin Clinic. Two months later, the
patient was re-admitted for similar symptoms, including two
weeks of shortness of breath, chest pain, and productive cough.
A thorough history revealed that the patient had continued to
smoke and drink on a daily basis and was non-compliant with his
previously prescribedmedications. Physical exam revealed bilateral
lower extremity edema. Labs showed an elevated D-dimer of 3080
and sub-therapeutic INR of 0.97. CT was subsequently performed
which demonstrated no evidence of pulmonary embolism, yet
revealed a large right-sided pneumonia, right pleural effusion, and
evidence of granulomatous disease. The patient was admitted to
the hospital and started on IV antibiotics, his home medications,
and anticoagulation with Lovenox and Coumadin.
Fig. 1. Contrast CT demonstrates saddle-type pulmonary embolus extending bilaterally into the pulmonary arteries (arrows).
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sided pleural effusion, which required multiple thoracenteses.
Analysis of the pleural effusion revealed hemorrhagic ﬂuid with
rare benign mesothelial cells but was negative for both malignancy
and tuberculosis. Due to the persistent nature of the patient’s
pleural effusion, the surgical team was consulted. Video assisted
thorascopic surgery (VATS) was advised. Anti-coagulation was
discontinued at this point, and the patient successfully underwent
ﬂuoroscopically guided IVC ﬁlter (Tulip Celect) placement with no
complications. There was no demonstrable suprarenal thrombus at
this time. Following the procedure, heparin therapy was restarted.
Ten days following this procedure, the patient experienced
a sudden onset of shortness of breath, and his vital signs revealed
both hypotension and tachycardia. Contrast CT demonstrated
a large saddle-type pulmonary embolus (Figs. 1 and 2) extending
bilaterally into the pulmonary arteries. Furthermore, EKG revealed
sinus tachycardia with classic signs of a prominent S wave in lead 1,
and a prominent Q wave and inverted T wave in lead 3.
The patient was emergently transported to the Interventional
Radiology suite. Access was gained through the right common
femoral vein. Inferior vena cavogram showed the infrarenal IVC
ﬁlter in correct position without the evidence of thrombus in the
IVC. The main pulmonary artery was cannulated and an angiogram
was performed. The large saddle embolism was seen within the
right and left pulmonary arteries, and there was associated occlu-
sion of the left upper and middle arterial segments with minimal
ﬂow in the left lower segment. Partial occlusion of the right mainFig. 2. Coronal reconstruction CT scan demonstratepulmonary trunk was also identiﬁed (Fig. 3). Catheter directed
thrombolysis and Angiojet thrombectomy of the PE were then
performed.
Four milligrams of tissue plasminogen activator (t-PA) were
infused into the left main pulmonary trunk, followed by infusion
of 2 mg of t-PA into the right pulmonary trunk. This was then fol-
lowed by pulse infusion of 10mg of t-PA directly into the thrombus.
After a 15 min period, Angiojet thrombectomy was performed.
Post-procedure angiogram showed near complete resolution of
the right and left pulmonary thrombi. Thus the patient was he-
modynamically stabilized. He tolerated the procedure without
any complications and did well post-operatively. In view of
a large saddle PE in spite of an IVC ﬁlter, he was placed on 3 mg
of Coumadin prophylaxis and discharged home to be followed
with his physicians for the regular checkups with INR and medical
management.
3. Discussion
There are several different features that make this case partic-
ularly interesting. First, the massive extent of the patient’s saddle
pulmonary embolismwas remarkable. Second, the patient suffered
this PE despite previous IVC ﬁlter placement just 10 days prior,
highlighting the importance of continued vigilance in patients
with known risk factors. Finally, the patient was successfully
treated using catheter directed thrombolysis and Angiojet throm-
bectomy, a more aggressive treatment option not yet considereds bilateral pulmonary artery emboli (arrows).
Fig. 3. CT-MIP- Reconstruction demonstrates only partial perfusion of the right lung
and practically no signiﬁcant perfusion on the left lung.
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ities gaining considerable favor for their life-saving potential in
speciﬁc patient populations.
Massive saddle pulmonary embolism is rare, carrying a risk
among individuals diagnosedwith PE of 2.6%. There arewell-known
risk factors for development of PE, including venous stasis, obesity,
trauma, advanced age, conﬁrmed DVT, and hypercoagulable states.4
However, a study of the International Cooperative Pulmonary
Embolism Registry found certain comorbidities to be speciﬁcally
associatedwithmassivePE, including congestive heart failure (CHF),
renal dysfunction, decreased left ventricular systolic ejection frac-
tion, cardiopulmonary disease and right ventricular thrombi.5 The
patient in this case had multiple risk factors for his PE, including
a history of CHF, COPD, pneumonia, persistent pulmonary effusion,
age greater than 40 years, obesity, bed rest and conﬁrmed DVT. He
was also known to be non-compliant with his outpatient anti-
coagulation therapy, resulting in a sub-therapeutic INR.
Due to this patient’s signiﬁcant risk factors, and in parti-
cular, conﬁrmed DVT, an IVC ﬁlter was placed. A randomized trial
comparing IVC ﬁlter placement versus no ﬁlter in patients with
known DVT found the device to provide favorable protection
against PE at 12-day follow-up.6 Nonetheless, at day 10 status
postIVC ﬁlter placement, the patient in this case developed
a massive and rare saddle pulmonary embolism. This highlightsthe importance of continually maintaining clinical suspicion in
high risk patients and bearing in mind the unique aspects of each
individual case. While IVC ﬁlters are known to minimize the risk of
subsequent, recurrent and fatal PE, they do not entirely eliminate
the possibility. Alternative sources of thrombi must be considered,
including those that originate suprarenal, from the upper ext-
remity, right atrium, and right ventricle. Furthermore, IVC ﬁlters are
designed to prevent passage of large emboli, and may allow prop-
agation of small emboli through the inferior vena cava.7
To date, there are no evidence-based guidelines detailing which
patients with acute PE are suitable candidates for treatment using
endovascular catheter directed therapies. The guideline set forth by
the American College of Chest Physicians for treatment of large
pulmonary embolism remains systemic thrombolytic therapy.2
Unfortunately, systemic thrombolytics are associated with a risk
ofmajor hemorrhage as high as 20% and a 3e5% risk of hemorrhagic
stroke in patient populations pre-screened for absolute contrain-
dications.3 Additionally, such treatment remains a non-viable
option in patients with contraindications to thrombolysis, hemo-
dynamically unstable patients who needmore emergent treatment,
or patients who fail to favorably respond to initial thrombolysis.
A large meta-analysis of 35 centers using CDT in treatment of
massive PE instead of systemic thrombolytics demonstrated
promising beneﬁts of localized endovascular treatment. In contrast
to a reported 77% survival rate in patients suffering massive PE
treated with systemic thrombolysis, the meta-analysis of CDT
found the pooled success rate of endovascular treatment, deﬁned
as stabilization of hemodynamic parameters, resolution of hypoxia
and survival to discharge from hospital, to be 86.5%.3
In conclusion, the patient we present in this case suffered a rar-
e and massive saddle pulmonary embolism, made even more
remarkable given the placement of an inferior vena cava ﬁlter just
days before. Use of CDT provided life-saving therapy in this partic-
ular patient and supports data that show promise for the future role
of CDT in the standard treatment of speciﬁc patient populations
with massive PE.
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